Men's Health
Study questions commercial men's health clinics services
In the journals
- Reviewed by Howard E. LeWine, MD, Chief Medical Editor, Harvard Health Publishing
When it comes to direct-to-consumer (DTC) men's health clinics, it's "buyer beware," as many offer costly treatments not supported by evidence and lack proper medical oversight, according to an investigative study published online Feb. 1, 2023, by Urology.
Researchers identified 233 DTC men's health clinics. These clinics offered treatments such as testosterone replacement therapy (TRT) and penile shock wave therapy and platelet-rich plasma (PRP) injections to treat erectile dysfunction. However, the researchers noted that the criteria for using TRT are still under debate and that most of the clinics did not follow standard protocols for testing and diagnosis of low testosterone levels. The effectiveness of penile shock wave therapy and PRP are still being studied and should only be offered in clinical trial settings, they added.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
About the Author
Matthew Solan, Executive Editor, Harvard Men's Health Watch
About the Reviewer
Howard E. LeWine, MD, Chief Medical Editor, Harvard Health Publishing
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
